These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35574370)
1. lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy. Xu C; Zhao J; Song J; Xiao M; Cui X; Xin L; Xu J; Zhang Y; Yi K; Hong B; Tong F; Tian S; Tan Y; Kang C; Fang C Front Oncol; 2022; 12():888922. PubMed ID: 35574370 [TBL] [Abstract][Full Text] [Related]
2. LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis. Li Y; Liu X; Cui X; Tan Y; Wang Q; Wang Y; Xu C; Fang C; Kang C Theranostics; 2021; 11(9):4516-4530. PubMed ID: 33754075 [No Abstract] [Full Text] [Related]
3. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788 [TBL] [Abstract][Full Text] [Related]
4. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner. Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093 [TBL] [Abstract][Full Text] [Related]
5. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167 [TBL] [Abstract][Full Text] [Related]
6. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas. Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529 [TBL] [Abstract][Full Text] [Related]
7. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells. Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527 [TBL] [Abstract][Full Text] [Related]
8. The N Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628 [No Abstract] [Full Text] [Related]
9. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related]
10. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β. Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147 [No Abstract] [Full Text] [Related]
12. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway. Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391 [TBL] [Abstract][Full Text] [Related]
13. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma. Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071 [TBL] [Abstract][Full Text] [Related]
15. RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 Pathway. Lin Y; Wei L; Hu B; Zhang J; Wei J; Qian Z; Zou D Front Oncol; 2021; 11():736941. PubMed ID: 34804926 [TBL] [Abstract][Full Text] [Related]
16. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres. Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544 [TBL] [Abstract][Full Text] [Related]
17. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
18. The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells. Yu T; Wang Y; Hu Q; Wu W; Wu Y; Wei W; Han D; You Y; Lin N; Liu N Oncotarget; 2017 Nov; 8(58):98348-98359. PubMed ID: 29228694 [TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF- Li W; Cai H; Ren L; Yang Y; Yang H; Liu J; Li S; Zhang Y; Zheng X; Tan W; Du G; Wang J Acta Pharm Sin B; 2022 Dec; 12(12):4390-4406. PubMed ID: 36562002 [TBL] [Abstract][Full Text] [Related]
20. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]